Top Insider Purchases of the Month -
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2019-07-16 | CRK | Comstock Resources Inc | Blue Star Exploration Corp | 10% | P - Purchase | $6.00 | +50,000,000 | 138,571,429 | +56% | +$300,000,000 | |||||
2019-06-28 | BECN | Beacon Roofing Supply Inc | Cd&r Investment Associates Ix, Ltd. | 10% | P - Purchase | $34.17 | +4,625,998 | 10,550,161 | +78% | +$158,081,454 | ||||||
2019-07-10 | TAXA | Liberty Tax, Inc. | Vintage Capital Management LLC | 10% | P - Purchase | $12.00 | +6,910,944 | 8,986,095 | +333% | +$82,931,327 | ||||||
| D | 2019-06-27 | BBIO | Bridgebio Pharma, Inc. | Viking Global Performance LLC | 10% | P - Purchase | $17.00 | +4,705,900 | 26,620,991 | +21% | +$80,000,300 | |||||
| D | 2019-06-27 | BBIO | Bridgebio Pharma, Inc. | Viking Global Investors LP | 10% | P - Purchase | $17.00 | +4,705,900 | 26,620,991 | +21% | +$80,000,300 | |||||
| D | 2019-07-01 | BBIO | Bridgebio Pharma, Inc. | Kkr Genetic Disorder L.P. | 10% | P - Purchase | $17.00 | +2,647,100 | 36,900,661 | +8% | +$45,000,700 | |||||
2019-07-03 | EIDX | Eidos Therapeutics, Inc. | Satvat Ali J. | Dir, 10% | P - Purchase | $29.90 | +882,353 | 24,575,501 | +4% | +$26,382,796 | ||||||
2019-07-03 | EIDX | Eidos Therapeutics, Inc. | Kumar Neil | CEO, 10% | P - Purchase | $29.90 | +882,353 | 24,575,501 | +4% | +$26,382,796 | ||||||
2019-07-03 | EIDX | Eidos Therapeutics, Inc. | Aguiar Eric | Dir, 10% | P - Purchase | $29.90 | +882,353 | 24,575,501 | +4% | +$26,382,796 | ||||||
2019-07-03 | EIDX | Eidos Therapeutics, Inc. | Bridgebio Pharma, Inc. | 10% | P - Purchase | $29.90 | +882,353 | 24,575,501 | +4% | +$26,382,796 | ||||||
2019-07-10 | SBGI | Sinclair Broadcast Group Inc | Smith David D | Exec COB, 10% | P - Purchase | $55.10 | +395,000 | 6,006,072 | +7% | +$21,764,500 | ||||||
2019-06-26 | ODT | Odonate Therapeutics, Inc. | Tang Kevin C | CEO, 10% | P - Purchase | $26.00 | +769,231 | 14,075,269 | +6% | +$20,000,006 | ||||||
| M | 2019-07-17 | ATEX | Pdvwireless, Inc. | Owl Creek Asset Management, L.P. | 10% | P - Purchase | $44.92 | +428,486 | 6,120,559 | +8% | +$19,247,340 | |||||
| M | 2019-06-20 | RUN | Sunrun Inc. | Tiger Global Management LLC | 10% | P - Purchase | $18.62 | +1,016,343 | 20,167,998 | +5% | +$18,926,316 | |||||
| D | 2019-06-28 | CMBM | Cambium Networks Corp | Slusky Alexander R | Dir, 10% | P - Purchase | $12.00 | +1,500,000 | 18,000 | -101% | +$18,000,000 | |||||
| D | 2019-06-28 | CMBM | Cambium Networks Corp | Amen Robert S | Dir, 10% | P - Purchase | $12.00 | +1,500,000 | 18,000 | -101% | +$18,000,000 | |||||
2019-06-28 | CMBM | Cambium Networks Corp | Vector Capital, L.L.C. | Dir, 10% | P - Purchase | $12.00 | +1,500,000 | 18,000 | -101% | +$18,000,000 | ||||||
| M | 2019-06-26 | RUN | Sunrun Inc. | Tiger Global Management LLC | 10% | P - Purchase | $18.59 | +866,725 | 21,868,400 | +4% | +$16,110,697 | |||||
| M | 2019-06-24 | RUN | Sunrun Inc. | Tiger Global Management LLC | 10% | P - Purchase | $18.60 | +833,677 | 21,001,675 | +4% | +$15,504,060 | |||||
| D | 2019-06-24 | PRVL | Prevail Therapeutics Inc. | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $17.00 | +882,352 | 13,822,463 | +7% | +$14,999,984 | |||||
| D | 2019-06-24 | PRVL | Prevail Therapeutics Inc. | Thompson Peter A. | Dir, 10% | P - Purchase | $17.00 | +882,352 | 13,822,463 | +7% | +$14,999,984 | |||||
| D | 2019-06-24 | PRVL | Prevail Therapeutics Inc. | Gordon Carl L | Dir, 10% | P - Purchase | $17.00 | +882,352 | 13,822,463 | +7% | +$14,999,984 | |||||
| D | 2019-06-24 | AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Dir, 10% | P - Purchase | $16.00 | +900,000 | 5,415,203 | +20% | +$14,400,000 | |||||
| D | 2019-06-24 | AKRO | Akero Therapeutics, Inc. | Apple Tree Partners Iv, L.P. | 10% | P - Purchase | $16.00 | +900,000 | 5,415,203 | +20% | +$14,400,000 | |||||
| M | 2019-06-26 | IMMU | Immunomedics Inc | Avoro Capital Advisors LLC | See Remarks, 10% | P - Purchase | $13.55 | +1,000,000 | 41,413,516 | +2% | +$13,548,000 | |||||
| D | 2019-07-02 | KRTX | Karuna Therapeutics, Inc. | Healy James | Dir | P - Purchase | $16.00 | +700,000 | 1,729,352 | +68% | +$11,200,000 | |||||
| M | 2019-06-21 | MGM | Mgm Resorts International | Meister Keith A. | Dir | P - Purchase | $27.81 | +380,651 | 20,354,560 | +2% | +$10,587,728 | |||||
| D | 2019-06-28 | MORF | Morphic Holding, Inc. | Novo Holdings A/s | 10% | P - Purchase | $15.00 | +666,667 | 2,645,446 | +34% | +$10,000,005 | |||||
2019-07-15 | LCRDX | Lord Abbett Credit Opportunities Fund | Christina & Robert Dow Foundation | 10% | P - Purchase | $10.11 | +989,120 | 0 | -100% | +$10,000,000 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Sonsini Peter W. | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Sandell Scott D | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Mott David M | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Makower Joshua | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Makhzoumi Mohamad | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Chang Carmen | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Behbahani Ali | Dir, 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Baskett Forest | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Barris Peter J | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | New Enterprise Associates 16, L.P. | 10% | P - Purchase | $3.50 | +2,857,142 | 7,225,676 | +65% | +$9,999,997 | ||||||
2019-06-26 | ODT | Odonate Therapeutics, Inc. | Boxer Capital, LLC | 10% | P - Purchase | $26.00 | +384,615 | 3,363,377 | +13% | +$9,999,990 | ||||||
2019-06-24 | GNCA | Genocea Biosciences, Inc. | Glaxosmithkline Plc | 10% | P - Purchase | $3.50 | +1,857,142 | 3,365,884 | +123% | +$6,499,997 | ||||||
| D | 2019-06-24 | AKRO | Akero Therapeutics, Inc. | Versant Venture Capital Vi, L.P. | 10% | P - Purchase | $16.00 | +400,000 | 4,104,858 | +11% | +$6,400,000 | |||||
| M | 2019-06-26 | MGM | Mgm Resorts International | Meister Keith A. | Dir | P - Purchase | $27.99 | +209,136 | 20,563,696 | +1% | +$5,853,432 | |||||
| M | 2019-06-27 | DOVA | Dova Pharmaceuticals Inc. | Perceptive Advisors LLC | 10% | P - Purchase | $13.35 | +427,209 | 3,553,060 | +14% | +$5,703,209 | |||||
| D | 2019-07-01 | ADPT | Adaptive Biotechnologies Corp | Viking Global Performance LLC | 10% | P - Purchase | $20.00 | +250,000 | 38,406,607 | +1% | +$5,000,000 | |||||
| D | 2019-07-01 | ADPT | Adaptive Biotechnologies Corp | Viking Global Investors LP | 10% | P - Purchase | $20.00 | +250,000 | 38,406,607 | +1% | +$5,000,000 | |||||
| D | 2019-07-01 | MORF | Morphic Holding, Inc. | Glaxosmithkline Plc | Dir | P - Purchase | $15.00 | +333,333 | 2,633,772 | +14% | +$4,999,995 | |||||
| D | 2019-07-01 | MORF | Morphic Holding, Inc. | Goyal Vikas | Dir | P - Purchase | $15.00 | +333,333 | 2,633,772 | +14% | +$4,999,995 | |||||
2019-06-28 | CSU | Capital Senior Living Corp | Levinson Sam | 10% | P - Purchase | $5.03 | +900,000 | 4,615,921 | +24% | +$4,527,000 | ||||||
| M | 2019-06-25 | AMAG | Amag Pharmaceuticals Inc. | Armistice Capital, LLC | 10% | P - Purchase | $8.87 | +498,016 | 4,000,000 | +14% | +$4,415,877 | |||||
| D | 2019-06-24 | AKRO | Akero Therapeutics, Inc. | Bitterman Kevin | Dir | P - Purchase | $16.00 | +270,000 | 505,099 | +115% | +$4,320,000 | |||||
| D | 2019-06-24 | AKRO | Akero Therapeutics, Inc. | Atlas Venture Fund Xi, L.P. | 10% | P - Purchase | $16.00 | +270,000 | 505,099 | +115% | +$4,320,000 | |||||
| M | 2017-09-25 | PGTK | Pacific Green Technologies Inc. | Fresh Air Investments (Canada) Ltd. | 10% | P - Purchase | $0.84 | +4,937,221 | 6,266,069 | +372% | +$4,157,579 | |||||
2019-07-17 | CHAP | Chaparral Energy, Inc. | Strategic Value Partners, LLC | 10% | P - Purchase | $5.18 | +782,482 | 6,190,257 | +14% | +$4,055,681 | ||||||
| D | 2019-06-24 | AKRO | Akero Therapeutics, Inc. | Venbio Global Strategic Fund II L.P. | 10% | P - Purchase | $16.00 | +250,000 | 3,954,858 | +7% | +$4,000,000 | |||||
2019-06-28 | VRML | Vermillion, Inc. | Schuler Jack W | 10% | P - Purchase | $0.80 | +5,000,000 | 22,378,242 | +29% | +$4,000,000 | ||||||
| D | 2019-06-24 | AKRO | Akero Therapeutics, Inc. | Royston Aaron | Dir | P - Purchase | $16.00 | +250,000 | 3,954,858 | +7% | +$4,000,000 | |||||
| D | 2019-06-28 | VRML | Vermillion, Inc. | Schuler Henri George | 10% | P - Purchase | $0.80 | +4,750,000 | 13,764,495 | +53% | +$3,800,000 | |||||
| D | 2019-07-02 | KRTX | Karuna Therapeutics, Inc. | Nelsen Robert | Dir, 10% | P - Purchase | $16.00 | +200,000 | 1,681,435 | +14% | +$3,200,000 | |||||
| D | 2019-07-02 | KRTX | Karuna Therapeutics, Inc. | Arch Venture Partners Ix, LLC | 10% | P - Purchase | $16.00 | +200,000 | 1,681,435 | +14% | +$3,200,000 | |||||
| M | 2019-07-12 | CHAP | Chaparral Energy, Inc. | Strategic Value Partners, LLC | 10% | P - Purchase | $5.72 | +554,321 | 5,947,990 | +10% | +$3,169,148 | |||||
| M | 2019-06-27 | MOTS | Motus Gi Holdings, Inc. | Feinberg Larry N | 10% | P - Purchase | $3.00 | +1,031,666 | 2,766,402 | +59% | +$3,095,499 | |||||
2019-06-27 | MOTS | Motus Gi Holdings, Inc. | Perceptive Advisors LLC | 10% | P - Purchase | $3.00 | +1,000,000 | 4,210,542 | +31% | +$3,000,000 | ||||||
2019-06-27 | ARQL | Arqule Inc | Nussbaum Ran | Dir | P - Purchase | $9.75 | +307,692 | 45,534 | -117% | +$2,999,997 | ||||||
| M | 2019-07-16 | FSLY | Fastly, Inc. | Abdiel Capital Management, LLC | 10% | P - Purchase | $21.29 | +137,702 | 5,055,681 | +3% | +$2,931,121 | |||||
| M | 2019-07-11 | FSLY | Fastly, Inc. | Abdiel Capital Management, LLC | 10% | P - Purchase | $20.32 | +137,515 | 4,781,448 | +3% | +$2,793,968 | |||||
| M | 2019-06-25 | FSLY | Fastly, Inc. | Abdiel Capital Management, LLC | 10% | P - Purchase | $17.25 | +153,248 | 4,503,734 | +4% | +$2,643,212 | |||||
| M | 2019-06-27 | CRVS | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Dir, 10% | P - Purchase | $3.72 | +657,344 | 6,624,928 | +11% | +$2,444,065 | |||||
| M | 2019-06-27 | CRVS | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $3.72 | +657,344 | 6,624,928 | +11% | +$2,444,065 | |||||
| M | 2019-03-13 | CNFR | Conifer Holdings, Inc. | Hakala Jeffrey Anthony | Dir | P - Purchase | $4.23 | +545,397 | 768,161 | +245% | +$2,307,692 | |||||
| M | 2019-07-02 | CHAP | Chaparral Energy, Inc. | Strategic Value Partners, LLC | 10% | P - Purchase | $4.64 | +486,895 | 5,715,451 | +9% | +$2,258,062 | |||||
2019-06-20 | DRRX | Durect Corp | First Eagle Investment Management, LLC | 10% | P - Purchase | $0.52 | +4,000,000 | 26,476,546 | +18% | +$2,080,000 | ||||||
2019-06-26 | ABBV | Abbvie Inc. | Chase William J | EVP, Finance, Administration | P - Purchase | $67.30 | +30,400 | 170,053 | +22% | +$2,045,920 | ||||||
| D | 2019-07-09 | VTVT | Vtv Therapeutics Inc. | Perelman Ronald O | 10% | P - Purchase | $1.65 | +1,212,121 | 20,276,593 | +6% | +$2,000,000 | |||||
2019-07-02 | OCX | Oncocyte Corp | Broadwood Partners, L.P. | 10% | P - Purchase | $2.00 | +1,000,000 | 18,199,679 | +6% | +$2,000,000 | ||||||
| D | 2019-06-25 | VTVT | Vtv Therapeutics Inc. | Perelman Ronald O | 10% | P - Purchase | $1.65 | +1,212,121 | 19,064,472 | +7% | +$2,000,000 | |||||
| D | 2019-07-01 | MORF | Morphic Holding, Inc. | Stampacchia Otello | Dir, 10% | P - Purchase | $15.00 | +133,333 | 2,969,582 | +5% | +$1,999,995 | |||||
| D | 2019-07-01 | MORF | Morphic Holding, Inc. | Omega Fund V, L.P. | 10% | P - Purchase | $15.00 | +133,333 | 2,969,582 | +5% | +$1,999,995 | |||||
| D | 2019-07-01 | MORF | Morphic Holding, Inc. | Nashat Amir | Dir | P - Purchase | $15.00 | +125,000 | 2,322,946 | +6% | +$1,875,000 | |||||
2019-06-24 | ELOX | Eloxx Pharmaceuticals, Inc. | Nussbaum Ran | Dir | P - Purchase | $9.00 | +200,000 | 7,212,186 | +3% | +$1,800,000 | ||||||
2019-06-24 | ELOX | Eloxx Pharmaceuticals, Inc. | Kariv Tomer | Dir | P - Purchase | $9.00 | +200,000 | 7,212,186 | +3% | +$1,800,000 | ||||||
2019-06-24 | ELOX | Eloxx Pharmaceuticals, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% | P - Purchase | $9.00 | +200,000 | 24,000 | -114% | +$1,800,000 | ||||||
2019-06-28 | MDCO | Medicines Co /de | Denner Alexander J | Dir | P - Purchase | $33.00 | +50,000 | 4,216,092 | +1% | +$1,650,000 | ||||||
2019-06-20 | SGMS | Scientific Games Corp | Perelman Ronald O | Dir, 10% | P - Purchase | $20.21 | +75,000 | 36,452,842 | 0% | +$1,515,750 | ||||||
2019-07-15 | SNSS | Sunesis Pharmaceuticals Inc | Aisling Capital Iv, LP | 10% | P - Purchase | $0.60 | +2,500,000 | 10,100,000 | +33% | +$1,500,000 | ||||||
| M | 2019-07-09 | DOVA | Dova Pharmaceuticals Inc. | Perceptive Advisors LLC | 10% | P - Purchase | $16.68 | +85,104 | 3,708,705 | +2% | +$1,419,612 | |||||
2019-07-05 | BXC | Bluelinx Holdings Inc. | Nokomis Capital, L.L.C. | 10% | P - Purchase | $18.17 | +73,476 | 1,279,469 | +6% | +$1,335,059 | ||||||
2019-06-28 | ACFN | Acorn Energy, Inc. | Loeb Jan H | Pres, CEO, 10% | P - Purchase | $0.24 | +5,409,062 | 7,350,105 | +279% | +$1,298,175 | ||||||
2019-07-05 | ABQQ | Ab International Group Corp. | Deng Chiyuan | CEO, 10% | P - Purchase | $2.00 | +600,000 | 2,000,400 | +43% | +$1,200,000 | ||||||
| M | 2019-06-21 | ETM | Entercom Communications Corp | Field Joseph M | COB Emeritus, 10% | P - Purchase | $5.96 | +200,000 | 12,226,235 | +2% | +$1,192,032 | |||||
2019-06-24 | PSNL | Personalis, Inc. | Ludlum Ken | Dir | P - Purchase | $17.00 | +70,000 | 115,833 | +153% | +$1,190,000 | ||||||
2019-06-28 | TRC | Tejon Ranch Co | Dt Four Partners, LLC | 10% | P - Purchase | $16.50 | +70,097 | 1,034,550 | +7% | +$1,156,601 | ||||||
| M | 2019-07-09 | CHAP | Chaparral Energy, Inc. | Strategic Value Partners, LLC | 10% | P - Purchase | $5.58 | +196,732 | 5,776,365 | +4% | +$1,098,623 | |||||
| M | 2019-07-17 | KALV | Kalvista Pharmaceuticals, Inc. | Cha Albert | Dir | P - Purchase | $17.79 | +61,280 | 1,420,429 | +5% | +$1,090,296 | |||||
2019-07-11 | GIII | G III Apparel Group Ltd /de/ | Goldfarb Morris | CEO, 10% | P - Purchase | $26.47 | +40,000 | 3,923,074 | +1% | +$1,058,800 | ||||||
| M | 2019-06-20 | CSU | Capital Senior Living Corp | Levinson Sam | 10% | P - Purchase | $4.28 | +242,177 | 3,715,921 | +7% | +$1,036,518 | |||||
2019-06-25 | CUK | Carnival Plc | Donald Arnold W | Pres, CEO | P - Purchase | $45.23 | +22,050 | 603,914 | +4% | +$997,267 | ||||||
2019-06-25 | CCL | Carnival Corp | Donald Arnold W | Pres, CEO | P - Purchase | $45.23 | +22,050 | 603,914 | +4% | +$997,267 | ||||||
| M | 2019-06-28 | WOR | Worthington Industries Inc | Blystone John B | Dir | P - Purchase | $39.88 | +25,000 | 189,370 | +15% | +$997,068 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |